How do Clorox and Altria compare by revenue?

Clorox reported revenue of $1.7B in Q2 2026, while Altria reported $5.8B in Q4 2025. Altria is 3.5× larger by last-quarter revenue.

Which is growing revenue faster, Clorox or Altria?

Clorox's latest revenue grew 0.3% year-over-year, versus -2.1% for Altria. Clorox is growing faster on a YoY basis.

Which has a higher gross margin, Clorox or Altria?

Clorox's gross margin is 43.2% vs Altria's 62.1%. Altria converts more of each revenue dollar into gross profit.

Which has a higher net margin, Clorox or Altria?

Clorox's net margin is 9.4% vs Altria's 19.1%. Altria has the higher bottom-line margin.

What is the 2-year revenue CAGR for Clorox vs Altria?

Over the trailing 8 quarters, Clorox compounded revenue at roughly -8.3% per year, versus 2.4% for Altria. Altria has the faster medium-term growth trajectory.

Where does this CLX vs MO data come from?

All figures are parsed directly from SEC EDGAR 10-Q / 10-K / 20-F / 6-K filings (for US-listed issuers) or EDINET filings (for Japanese issuers), then normalised into a common schema. Numbers update automatically as new filings are released.

vs

Side-by-side financial comparison of Clorox (CLX) and Altria (MO), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.

Altria is the larger business by last-quarter revenue ($5.8B vs $1.7B, roughly 3.5× Clorox). Altria runs the higher net margin — 9.4% vs 19.1%, a 9.7% gap on every dollar of revenue. On growth, Clorox posted the faster year-over-year revenue change (0.3% vs -2.1%). Over the past eight quarters, Altria's revenue compounded faster (2.4% CAGR vs -8.3%).

CloroxCLXEarnings & Financial Report

NYSE · Consumer Staples · Household Products

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

AltriaMOEarnings & Financial Report

NYSE · Consumer Staples · Tobacco

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retai...

CLX vs MO — Head-to-Head

Bigger by revenue

3.5× larger

$5.8B

$1.7B

Growing faster (revenue YoY)

CLX

+2.4% gap

0.3%

-2.1%

Higher net margin

9.7% more per $

19.1%

9.4%

Faster 2-yr revenue CAGR

Annualised

2.4%

-8.3%

Income Statement — Q2 2026 vs Q4 2025

Metric	CLX	MO
Revenue	$1.7B	$5.8B
Net Profit	$157.0M	$1.1B
Gross Margin	43.2%	62.1%
Operating Margin	—	28.2%
Net Margin	9.4%	19.1%
Revenue YoY	0.3%	-2.1%
Net Profit YoY	-15.6%	-63.2%
EPS (diluted)	$1.29	$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.

Revenue

CLX

Q4 25	$1.7B	$5.8B
Q3 25	—	$6.1B
Q2 25	$2.0B	$6.1B
Q1 25	$1.7B	$5.3B
Q4 24	$1.7B	$6.0B
Q3 24	$1.8B	$6.3B
Q2 24	$1.9B	$6.2B
Q1 24	$1.8B	$5.6B

Net Profit

CLX

Q4 25	$157.0M	$1.1B
Q3 25	—	$2.4B
Q2 25	$332.0M	$2.4B
Q1 25	$186.0M	$1.1B
Q4 24	$193.0M	$3.0B
Q3 24	$99.0M	$2.3B
Q2 24	$216.0M	$3.8B
Q1 24	$-51.0M	$2.1B

Gross Margin

CLX

Q4 25	43.2%	62.1%
Q3 25	—	62.8%
Q2 25	46.5%	63.1%
Q1 25	44.6%	61.8%
Q4 24	43.8%	60.3%
Q3 24	45.8%	60.8%
Q2 24	46.5%	59.2%
Q1 24	42.2%	58.8%

Operating Margin

CLX

Q4 25	—	28.2%
Q3 25	—	53.2%
Q2 25	20.6%	52.9%
Q1 25	15.2%	34.0%
Q4 24	14.1%	48.2%
Q3 24	10.0%	50.4%
Q2 24	14.5%	40.8%
Q1 24	-2.3%	48.0%

Net Margin

CLX

Q4 25	9.4%	19.1%
Q3 25	—	39.1%
Q2 25	16.7%	39.0%
Q1 25	11.2%	20.5%
Q4 24	11.4%	50.9%
Q3 24	5.6%	36.6%
Q2 24	11.4%	61.2%
Q1 24	-2.8%	38.2%

EPS (diluted)

CLX

Q4 25	$1.29	$0.67
Q3 25	—	$1.41
Q2 25	$2.68	$1.41
Q1 25	$1.50	$0.63
Q4 24	$1.54	$1.78
Q3 24	$0.80	$1.34
Q2 24	$1.74	$2.21
Q1 24	$-0.41	$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.

Metric	CLX	MO
Cash + ST InvestmentsLiquidity on hand	$227.0M	$4.5B
Total DebtLower is stronger	—	$25.7B
Stockholders' EquityBook value	$-125.0M	$-3.5B
Total Assets	$5.6B	$35.0B
Debt / EquityLower = less leverage	—	—

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Cash + ST Investments

CLX

Q4 25	$227.0M	$4.5B
Q3 25	—	$3.5B
Q2 25	$167.0M	$1.3B
Q1 25	$226.0M	$4.7B
Q4 24	$290.0M	$3.1B
Q3 24	$278.0M	$1.9B
Q2 24	$202.0M	$1.8B
Q1 24	$219.0M	$3.6B

Total Debt

CLX

Q4 25	—	$25.7B
Q3 25	—	$25.7B
Q2 25	$2.5B	$24.7B
Q1 25	—	$26.1B
Q4 24	—	$24.9B
Q3 24	—	$25.2B
Q2 24	$2.5B	$25.0B
Q1 24	—	$25.0B

Stockholders' Equity

CLX

Q4 25	$-125.0M	$-3.5B
Q3 25	—	$-2.6B
Q2 25	$321.0M	$-3.3B
Q1 25	$27.0M	$-3.5B
Q4 24	$-41.0M	$-2.2B
Q3 24	$60.0M	$-3.5B
Q2 24	$328.0M	$-3.0B
Q1 24	$91.0M	$-5.1B

Total Assets

CLX

Q4 25	$5.6B	$35.0B
Q3 25	—	$35.0B
Q2 25	$5.6B	$32.3B
Q1 25	$5.5B	$35.8B
Q4 24	$5.6B	$35.2B
Q3 24	$5.5B	$34.2B
Q2 24	$5.8B	$34.4B
Q1 24	$5.8B	$36.5B

Debt / Equity

CLX

Q4 25	—	—
Q3 25	—	—
Q2 25	7.74×	—
Q1 25	—	—
Q4 24	—	—
Q3 24	—	—
Q2 24	7.56×	—
Q1 24	—	—

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.

Metric	CLX	MO
Operating Cash FlowLast quarter	—	$3.3B
Free Cash FlowOCF − Capex	—	$3.2B
FCF MarginFCF / Revenue	—	54.4%
Capex IntensityCapex / Revenue; lower = less reinvestment burden	—	1.6%
Cash ConversionOCF / Net Profit; >1× = earnings back up with cash	—	2.93×
TTM Free Cash FlowTrailing 4 quarters	—	$9.1B

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Operating Cash Flow

CLX

Q4 25	—	$3.3B
Q3 25	—	$3.1B
Q2 25	$294.0M	$205.0M
Q1 25	$286.0M	$2.7B
Q4 24	$180.0M	$3.3B
Q3 24	$221.0M	$2.6B
Q2 24	$340.0M	$-75.0M
Q1 24	$182.0M	$2.9B

Free Cash Flow

CLX

Q4 25	—	$3.2B
Q3 25	—	$3.0B
Q2 25	$219.0M	$173.0M
Q1 25	$233.0M	$2.7B
Q4 24	$127.0M	$3.3B
Q3 24	$182.0M	$2.6B
Q2 24	$259.0M	$-104.0M
Q1 24	$127.0M	$2.8B

FCF Margin

CLX

Q4 25	—	54.4%
Q3 25	—	50.1%
Q2 25	11.0%	2.8%
Q1 25	14.0%	51.0%
Q4 24	7.5%	55.1%
Q3 24	10.3%	41.2%
Q2 24	13.6%	-1.7%
Q1 24	7.0%	51.0%

Capex Intensity

CLX

Q4 25	—	1.6%
Q3 25	—	0.9%
Q2 25	3.8%	0.5%
Q1 25	3.2%	0.7%
Q4 24	3.1%	0.8%
Q3 24	2.2%	0.5%
Q2 24	4.3%	0.5%
Q1 24	3.0%	0.6%

Cash Conversion

CLX

Q4 25	—	2.93×
Q3 25	—	1.30×
Q2 25	0.89×	0.09×
Q1 25	1.54×	2.53×
Q4 24	0.93×	1.10×
Q3 24	2.23×	1.14×
Q2 24	1.57×	-0.02×
Q1 24	—	1.35×

Financial Flow Comparison

Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.